EndovascuLar RegIstry Evaluating SafeTy, Efficacy and Patient Comfort (ELITE)
NCT ID: NCT03412942
Last Updated: 2018-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2017-02-01
2019-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients with Symptomatic Peripheral Vascular Disease from Stenosis or Occlusion of the Femoropopliteal Artery
NCT04584632
Efficacy of Rotational Atherectomy System Associated With Drug Coated Balloon Angioplasty in Limb Ischemia
NCT04276311
The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)
NCT06315023
Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries
NCT02522884
Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions
NCT07122167
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Many prior studies have studied the safety and efficacy of vascular closure devices. However, it is substantial to also study device success when in the hands of one specific operator. This study will examine 100 consecutive subjects which the FISH vascular closure device will be used on, and examine outcomes in the following way:
Primary Endpoint:
o Safety: Severe adverse events rate (SAE) (Device related only) (transfusion/vessel occlusion)
Secondary Endpoints:
* Safety: minor adverse event rate (MAE) (Hematoma)
* Success rate (Time to Hemostasis (TTH) \< 10min)
* Time to Hemostasis (TTH) mm:ss - measured from sheath pull to absence of arterial bleeding.
* Time to Ambulation (TTA) hh:mm - measured form sheath pull to walking 20 feet.
* Patient comfort - subjective measure (see scale below) measured baseline (pre-procedure/ post procedure/ 15 days and 30 days)
* Physician Confidence and Comfort (C\&C)(measured every 10 patients)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment with FISH device
Vascular closure to be performed with FISH device.
FISH SP
The device will be used to close the femoral artery after angiogram and/or endovascular procedure.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FISH SP
The device will be used to close the femoral artery after angiogram and/or endovascular procedure.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Deborah Heart and Lung Center
OTHER
Morris Innovative Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Kovach, MD
Role: PRINCIPAL_INVESTIGATOR
Physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Florida Research Network, LLC
Gainesville, Florida, United States
Healient Physician Group
Leawood, Kansas, United States
North Memorial
Robbinsdale, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Bret Wiechmann, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2K17-10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.